Cited by 5Schizophrenia research and treatmentHeart Rate Variability and Autonomic ControlParkinson's Disease Mechanisms and Treatments

Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients

Open access
Suda, Akira, Hattori, Saki, Kishida, Ikuko, Miyauchi, Masatoshi, Shiraishi, Yohko, Fujibayashi, Mami, Tsujita, Natsuki, Ishii, Chie +3 more·2018·Neuropsychiatric Disease and Treatment

Abstract

Objective: Long-acting injections (LAIs) of antipsychotics show distinct pharmacokinetic profiles from oral antipsychotics (OAPs). Although there may be differences in adverse event frequency, any differences in their effects on autonomic nervous system (ANS) remain unclear. Patients and methods: In total, 270 schizophrenic patients were recruited in this study: 241 received OAPs (risperidone, olanzapine, quetiapine, or aripiprazole) and 29 received LAIs (risperidone LAI, aripiprazole LAI, or paliperidone palmitate) as monotherapy. Heart rate variability was measured as an index of ANS activity, and the low-frequency (0.03–0.15 Hz) component, high-frequency (0.15–0.40 Hz) component, and total power (0.03–0.40 Hz) were calculated. Components were compared between the groups using t-tests. Results: A significant difference was detected in the low-frequency component between the OAP and LAI groups ( P =0.046). No significant difference was found in total power or the high-frequency component between the two groups. Conclusion: Compared with OAPs, LAIs have fewer adverse effects on ANS activity, particularly the low-frequency component, as determined using a spectral analysis of heart rate variability. Keywords: long-acting injectable antipsychotics, autonomic nervous system, heart rate variability, adverse effect

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ndt.s173617

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Long-acting injectable antipsychotics have fewer adverse effects on ANS activity, particularly sympathetic nervous system activity as assessed through LF-HRV, compared with oral antipsychotics.

    “Lastly, the effects of APs on ANS activity may also be related to their route of administration as one study to date has provided evidence that long-acting injectable APs have fewer adverse effects on ANS activity, and particularly SNS activity (as assessed through LF-HRV), in comparison to oral APs54.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Suda, A., Hattori, S., Kishida, I., Miyauchi, M., Shiraishi, Y., Fujibayashi, M., Tsujita, N., Ishii, C., Ishii, N., Moritani, T., & Hirayasu, Y.
Affiliations
  • Yokohama City University (JP)
  • Setsunan University (JP)
  • Kyoto University (JP)
  • Kyoto Sangyo University (JP)
Corresponding author
Suda, Akira
Venue
Neuropsychiatric Disease and Treatment
Published
2018-09
Volume
Volume 14
Pages
2361-2366
ISSN
  • 1176-6328 (ISSN-L)
  • 1178-2021
OpenAlex
W2890487346
Cited by
5
References
52
Citations by year
2023: 1 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 1
FWCI
0.59
Type
journal article
Language
en
Open access
Locations
  • Neuropsychiatric Disease and Treatment (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
Japan Society for the Promotion of Science (16K10254)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
long-acting injectable antipsychotics, oral antipsychotics, autonomic nervous system activity, heart rate variability, schizophrenia, low-frequency components, spectral analysis, risperidone, aripiprazole, paliperidone palmitate, adverse effects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review